Skip to content

ARIAD PHARMACEUTICALS INC

CIK 0000884731

← back to feed
Revenue (TTM)
$178.81M
+12.7% YoY Q3 Oct 2016
Net Income (TTM)
−$27.22M
−42.2% YoY Q3 Oct 2016
EPS Diluted (TTM)
−$0.20
−44.1% YoY Q3 Oct 2016
Gross Margin
98.2%
Q3 Oct 2016
Operating Margin
-78.8%
Q3 Oct 2016
Net Margin
-15.2%
Q3 Oct 2016
Free Cash Flow (TTM)
−$187.6M
Q3 Oct 2016
Cash
$305.04M
Q3 Oct 2016
Total Debt
$552.92M
Q3 Oct 2016
Shares Outstanding
194.2M sh
Q3 Oct 2016

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings